CHA2DS2-VASc score stratifies mortality risk in patients with and without atrial fibrillation
Objectives The CHA2DS2-VASc score is the preferred risk model for anticoagulation decision-making in atrial fibrillation (AF) patients. Recent studies have found this score to have prognostic value in other cardiovascular diseases. We assessed the relationships between CHA2DS2-VASc score and long-te...
Saved in:
| Main Authors: | Serge C Harb, Leslie Cho, Tom Kai Ming Wang, Venu Menon, Paul C Cremer, Wael Jaber, David Nemer, Yuping Wu, Osama Wazni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-12-01
|
| Series: | Open Heart |
| Online Access: | https://openheart.bmj.com/content/8/2/e001794.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CHA2DS2-VASc Score Is Associated With Prognosis in Patients With Acute Ischemic Stroke Without Atrial Fibrillation
by: Mingjuan Song, MM, et al.
Published: (2025-02-01) -
The Prognostic Significance of CHA2DS2-VASc Score in Sudden Hearing Loss
by: Sahin Ogreden, et al.
Published: (2024-07-01) -
Correlation between CHA2DS2-VASc Score and Glaucoma Treatment and Prognosis
by: Yoav Y. Pikkel, et al.
Published: (2018-01-01) -
Total Adiponectin Is Inversely Associated with Platelet Activation and CHA2DS2-VASc Score in Anticoagulated Patients with Atrial Fibrillation
by: Roberto Carnevale, et al.
Published: (2014-01-01) -
CHA2DS2‐VASc score and prior oral anticoagulant use on endovascular treatment for acute ischemic stroke
by: Yukihiro Imaoka, et al.
Published: (2024-12-01)